Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Inflammopharmacology ; 19(5): 243-4, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21877123

RESUMEN

In their systematic review, Zhang et al. evaluate randomized controlled trials on the efficacy of Botulinum toxin type A (BoNTA) in helping patients with musculoskeletal disorders. Scoring each trial according to the Jadad scale they note that the studies range from 1 to 5 with an average of 4.1, which they interpret as a testimony of the high quality of the studies included. Unfortunately, we cannot share the author's enthusiasm, as a perfect Jadad score of 5 is no guarantee that a study is of good quality.


Asunto(s)
Toxinas Botulínicas Tipo A/uso terapéutico , Enfermedades Musculoesqueléticas/tratamiento farmacológico , Sistema Musculoesquelético/efectos de los fármacos , Dolor/tratamiento farmacológico , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA